Curis (CRIS) Other Non-Current Assets (2010 - 2026)
Curis (CRIS) reported Other Non-Current Assets of $544000.0 for Q1 2026, little changed on a YoY basis from $544000.0 in Q1 2025, and little changed quarter-over-quarter from $544000.0 in Q4 2025.
Curis (CRIS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Curis has reported Other Non-Current Assets for 17 years, with the latest figure at $544000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $544000.0; the trailing twelve-month figure through Mar 2026 stood at $544000.0 (changed 0.0% YoY), and the FY2025 full-year result was $544000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $544000.0, roughly flat from $544000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.5 million in Q2 2023, with the low at $544000.0 in Q3 2023.
- Historically, Other Non-Current Assets has averaged $855117.6 across 5 years, with a median of $544000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets soared 299.84% — and 2024, when it sank 78.57%.
- Curis' Other Non-Current Assets stood at $2.0 million in 2022, then plunged by 73.1% to $544000.0 in 2023, then changed by 0.0% to $544000.0 in 2024, then changed by 0.0% to $544000.0 in 2025, then changed by 0.0% to $544000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $544000.0 (Q1 2026), $544000.0 (Q4 2025), and $544000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 544,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 544,000.00 |
| Dec 31, 2025 | 544,000.00 |
| Sep 30, 2025 | 544,000.00 |
| Jun 30, 2025 | 544,000.00 |
| Mar 31, 2025 | 544,000.00 |
| Dec 31, 2024 | 544,000.00 |
| Sep 30, 2024 | 544,000.00 |
| Jun 30, 2024 | 544,000.00 |
| Mar 31, 2024 | 544,000.00 |
| Dec 31, 2023 | 544,000.00 |
| Sep 30, 2023 | 544,000.00 |
| Jun 30, 2023 | 2.54 Mn |
| Mar 31, 2023 | 635,000.00 |
| Dec 31, 2022 | 2.02 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 635,000.00 |
| Mar 31, 2022 | 700,000.00 |
| Dec 31, 2021 | 700,000.00 |
| Mar 31, 2021 | 800,000.00 |
| Dec 31, 2020 | 3,000.00 |